| Trial Status | Recruiting |
| Dates | Date of activation: 19-Dec-11 |
| Data management at EORTC | Mailbox |
| Phase | 2-3 |
| Randomized trial | Yes |
| Type | Hemato-malign |
| Targeted Sample size | - |
| Number of steps | 1 |
| Drug | Mercaptopurine Tioguanine Clofarabine Cytarabine Daunorubicin Doxorubicin Etoposide Leucovorin Methotrexate Prednisolone Prednisone Vinblastine Vincristine Vindesine Dexamethasone |
| Study Staff | Jean-Pierre Marie (Study Coordinator) - Assistance Publique - Hôpitaux de Paris - Hopital Saint Antoine AP-HP, Paris Stefan Suciu (Statistician) - EORTC Headquarters, Brussels Séraphine Rossi (Data Manager) - EORTC Headquarters, Brussels Safaa Ramadan (Coordinating Physician) - EORTC Headquarters, Brussels Hilde Breyssens (Project Manager) - EORTC Headquarters, Brussels, hilde.breyssens( at )eortc.be, +32 27741004 |
| Type of cancer | Acute Lymphocytic Leukemia |
| Participating Groups | Hemato-Oncologie Volwassenen Nederland(Coordinating Group) EORTC Leukemia Group |
| Centers authorized by EORTC | Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101 Universitair Ziekenhuis Gent (Gent, Belgium) - Inst. 104 A.Z. St. Jan (Brugge, Belgium) - Inst. 109 ZNA Stuivenberg Ziekenhuis (Antwerpen, Belgium) - Inst. 113 ZNA Middelheim (Antwerpen, Belgium) - Inst. 114 Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121 Centre Hospitalier Regional De La Citadelle (Liege, Belgium) - Inst. 145 U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) - Inst. 147 H. Hartziekenhuis (Roeselare, Belgium) - Inst. 1200 Assistance Publique - Hôpitaux de Paris - Hopital Saint Antoine AP-HP (Paris, France) - Inst. 203 Jeroen Bosch Ziekenhuis ('s-Hertogenbosch, The Netherlands) - Inst. 22 Erasmus MC - Daniel den Hoed Cancer Center (Rotterdam, The Netherlands) - Inst. 302 Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304 Vrije Universiteit Medisch Centrum (Amsterdam, The Netherlands) - Inst. 308 Onze Lieve Vrouw Gasthuis (Amsterdam, The Netherlands) - Inst. 309 Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310 Academisch Ziekenhuis Maastricht (Maastricht, The Netherlands) - Inst. 324 HagaZiekenhuis ('S Gravenhage - Den Haag, The Netherlands) - Inst. 330 University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335 |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | |
| EudraCT | 2008-005798-36 |
| Protocol documents in PDF (requires password) | Study documentation |